Trial Profile
Study of effectiveness of golimumab administered directly after infliximab in rheumatoid arthritis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Aug 2018
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Therapeutic Use
- 03 Aug 2018 New trial record
- 28 Jul 2018 Results published in the Drugs in R and D